Answers are grounded in this paper and cite their sources.
Muramidasuria is most consistently demonstrated in acute monocytic leukemia. Detection of muramidasuria in some patients with chronic granulocytic leukemia led to a comparative study of 14 patients, demonstrating that the six patients with muramidasuria differed from the remaining eight patients in several ways. All were Philadelphia-chromosome negative. Serum muramidase levels were higher in the negative group, and the patients were older, with male-sex predominating, platelet counts were lower, and responsiveness to busulfan was poorer than in the positive group.
No takes yet. Share an insight, caveat, or question.
Perillie et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: